Table 4.
Vasculitis* | Diabetes Mellitus(18) | Hypertension(19) | Osteoarthritis(20) | Systemic Sclerosis (10) | |
---|---|---|---|---|---|
| |||||
n = 692 | n = 164 | n = 514 | n = 241 | n = 49 | |
Identity** | 10.7 (±5.1) | NC | NC | NC | NC |
Timeline | 4.1 (±0.8) | 3.9 (±0.8) | 3.6 (±0.4) | 4.2 (±0.8) | 4.2 (±0.6) |
Cyclical | 3.2 (±1.0) | 2.8 (±0.7) | 3.2 (±0.8) | 3.6 (±0.8) | 3.5 (±1.0) |
Consequences | 3.8 (±0.8) | 2.9 (±0.6) | 2.6 (±0.6) | 2.8 (±0.8) | 3.8 (±0.8) |
Emotional repr. | 3.1 (±1.0) | 2.0 (±0.6) | 2.6 (±0.7) | 2.4 (±0.8) | 3.1 (±1.0) |
Personal control | 3.3 (±0.8) | 3.9 (±0.6) | 3.5 (±0.7) | 3.1 (±0.6) | 2.9 (±0.7) |
Treatment control | 3.3 (±0.7) | 4.6 (±0.9) | 3.5 (±0.6) | 2.8 (±0.6) | 3.0 (±0.6) |
Illness coherence | 3.4 (±1.0) | 3.5 (±0.9) | NR | 3.6 (±0.8) | 3.1 (±1.0) |
Vasculitis types include Behçet’s disease (n=48), central nervous system vasculitis (n=12), eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (n=121), giant cell arteritis (n=32), granulomatosis with polyangiitis (Wegener’s) (n=332), IgA vasculitis (Henoch-Schönlein) (n=12), microscopic polyangiitis (n=42), polyarteritis nodosa (n=36), and Takayasu’s arteritis (n=57).
Identity was scored on scale from 0–22. All other dimensions were scored on a scale from 1–5. NC = not comparable across diseases due to disease-specific modifications to IPQ-R. NR = not reported.